Tilray Receives Approval for Portugal’s First Medical Cannabis Extract
Tilray Brands, Inc. (Nasdaq:TLRY) has received approval from Portuguese regulators for its first medical cannabis extract, Tilray Oral Solution THC 5 CBD 20, marking a significant advancement in the medical cannabis sector within the country.
- Regulatory Approval for Cannabis Extract: Following its previously approved whole flower THC 18, Tilray has now gained regulatory approval for its cannabis extract in Portugal.
- Enhancing Patient Care: This approval aims to improve the accessibility and quality of medical cannabis for patients in Portugal.
- Anticipated Product Launch: The approved cannabis extract is expected to be available in late spring, providing new therapeutic options for patients with specific conditions.
Denise Faltischek, Chief Strategy Officer and Head of International at Tilray Brands, Inc., commented, “This is a monumental step forward for patient care in Portugal. With the approval of our first medical cannabis extract, we are proud to be at the forefront of medical cannabis research and accessibility and continue to demonstrate our commitment to providing innovative, safe, and effective therapeutic options to patients. We continue to pioneer the future of medical cannabis, furthering our mission to empower and inspire individuals to live their best lives.”
About Tilray Medical
Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios, and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in over 20 countries and across five continents.
